Seattle Cannabis Company Capitalizes on Surging Demand
The increase in the number of states that permit recreational and medical use of cannabis means that growers, processors and manufacturers of cannabis products often can’t keep up with growing demand. One Seattle weed manufacturer is poised to sell products across state lines, easing shortages. This could drive the company’s shares sky-high.
Get all the details on this potential blockbuster!

EZL Insider Trading (Euroz)

Insider Ownership Percentage: N/A
Insider Buying (Last 12 Months): A$119,231.57
Insider Selling (Last 12 Months): A$0.00

Euroz Insider Trading History Chart

This chart shows the insider buying and selling history at Euroz by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Euroz Share Price & Price History

Current Price: A$0.00
Price Change: +0.30 (1.20%)
As of 05/13/2020 01:00 AM ET

This chart shows the closing price history over time for EZL up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Seattle Cannabis Company Capitalizes on Surging Demand
The increase in the number of states that permit recreational and medical use of cannabis means that growers, processors and manufacturers of cannabis products often can’t keep up with growing demand. One Seattle weed manufacturer is poised to sell products across state lines, easing shortages. This could drive the company’s shares sky-high.
Get all the details on this potential blockbuster!

Euroz Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
2/26/2021Robin RomeroInsiderBuy22,575A$1.46A$32,936.93
2/24/2021Robert BlackInsiderIssued21,065A$1.47A$30,902.36
10/9/2020Anthony BrittainInsiderTransfer257,830A$1.16A$297,793.65
8/27/2020Russell KaneInsiderBuy5,000A$1.18A$5,885.00
8/25/2020Jay HughesInsiderBuy17,359A$1.16A$20,049.65
8/7/2020Andrew McKenzieInsiderIssued191,162A$1.06A$202,631.72
6/25/2020Jay HughesInsiderBuy60,000A$1.01A$60,360.00
6/19/2020Andrew McKenzieInsiderBuy50,000A$1.03A$51,650.00
3/23/2020Robert BlackInsiderTransfer45,261A$0.80A$36,208.80
2/21/2020Greg ChessellInsiderIssued34,684A$1.01A$34,892.10
8/7/2019Greg ChessellInsiderIssued86,532A$1.09A$94,319.88
6/28/2019Andrew McKenzieInsiderIssued78,782A$1.19A$93,750.58
4/29/2019Robert BlackInsiderTransfer20,000A$1.19A$23,800.00
3/26/2019Russell KaneInsiderBuy3,000A$1.14A$3,420.00
2/20/2019Robert BlackInsiderTransfer30,000A$1.18A$35,400.00
2/18/2019Greg ChessellInsiderBuy40,000A$1.18A$47,200.00
1/30/2019Greg ChessellInsiderIssued28,406A$1.12A$31,814.72
11/15/2018Russell KaneInsiderTransfer357,586A$1.17A$416,587.69
See Full Table
Insider Buying at Euroz?
Sign-up to receive InsiderTrades.com's daily insider buying and selling report for Euroz and related companies.

SEC Filings (Institutional Ownership Changes) for Euroz (ASX:EZL)

Euroz Limited, a diversified financial services company, provides stockbroking, corporate finance, funds management, investing, and wealth management services to institutional and corporate clients, and high net worth individuals primarily in Australia. The company offers equities research, institutional dealing, and private clients dealing services, as well as corporate advisory services, including equity capital raising and undertaking, merger and acquisitions advisory, strategic planning and review, privatization and reconstruction, and takeover/takeover response services. It also provides portfolio management, strategic financial planning advisory, and portfolio administration services; and raises equity capital through initial public offerings, placements, and rights issues. Euroz Limited was incorporated in 1961 and is based in Perth, Australia
Read More on Euroz

Today's Range

Now: N/A

50 Day Range

MA: N/A

52 Week Range

Now: N/A

Volume

27,692 shs

Average Volume

N/A

Market Capitalization

N/A

P/E Ratio

N/A

Dividend Yield

5.01%

Beta

N/A

Who are the company insiders with the largest holdings of Euroz?

Euroz's top insider investors include:
  1. Andrew McKenzie (Insider)
  2. Anthony Brittain (Insider)
  3. Greg Chessell (Insider)
  4. Jay Hughes (Insider)
  5. Robert Black (Insider)
  6. Robin Romero (Insider)
  7. Russell Kane (Insider)
Tiny Stock Taking on Big Pharma
Big Pharma doesn't want to CURE depression. The longer we stay depressed, the more money they make. But one new company is changing all that.
And it's not too late to capitalize today